Biotech · Private company
Asher Biotherapeutics, Inc.
Track this companyFree. Adds Asher Biotherapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- etakafusp alfa (AB248)Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- pembrolizumabPhase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)PHASE1 · RECRUITING · started Sep 16, 2025ClinicalTrials.gov NCT07037758 · fetched Nov 12, 2026
- AB821 in Adult Participants With Locally Advanced or Metastatic Solid TumorsPHASE1 · RECRUITING · started Aug 5, 2025ClinicalTrials.gov NCT07027488 · fetched Nov 12, 2026
- A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 4, 2023ClinicalTrials.gov NCT05653882 · fetched Nov 12, 2026